Abstract
Metastatic liver cancer, also known as secondary liver cancer, is formed by metastasis from cancer of other organs to the liver and is an indicator of late-stage malignancy. Metastatic liver cancer, if untreated, can result in a poor outcome. The median survival time of patients with this diagnosis is no more than 2 years, with patients rarely surviving for more than 5 years [1]. Optimal treatment for metastatic liver cancer remains a challenge in the modern era. Although multiple therapeutic methods such as surgical resection, liver transplantation, chemotherapy, transhepatic portal or arterial embolization, intratumor local injection, hyperthermic and hypothermic therapy, and gene therapy have been introduced, only surgical resection has achieved satisfactory results.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Luna-Perez P, et al. The natural history of liver metastases from colorectal cancer. Arch Med Res. 1998;29(4):319–24.
Shah SA, et al. Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg. 2007;205(5):676–83.
Kan N. Analysis of long-term (5-year) survival in patients with metastatic breast cancer to the liver. Gan To Kagaku Ryoho. 2006;33(12):1780–4.
Scheele J, et al. Resection of colorectal liver metastases. World J Surg. 1995;19(1):59–71.
Di Carlo V, et al. Repeated hepatectomy for colorectal metastasis. Ann Ital Chir. 1997;68(6):775–80.
Gazzaniga GM, et al. Repeated hepatic resections for recurrent metastasis of colorectal cancer. Hepatogastroenterology. 1995;42(4):383–6.
Gayowski TJ, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994;116(4):703–10; discussion 710–1.
Vandeweyer D, et al. Influence of resection margin on survival in hepatic resections for colorectal liver metastases. HPB (Oxford). 2009;11(6):499–504.
Abdalla EK, et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13(10):1271–80.
Elias D, et al. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg. 2003;90(5):567–74.
Moroz P, Salama PR, Gray BN. Resecting large numbers of hepatic colorectal metastases. ANZ J Surg. 2002;72(1):5–10.
Rees M, et al. One hundred and fifty hepatic resections: evolution of technique towards bloodless surgery. Br J Surg. 1996;83(11):1526–9.
Ohlsson B, Stenram U, Tranberg KG. Resection of colorectal liver metastases: 25-year experience. World J Surg. 1998;22(3):268–76; discussion 276–7.
Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg. 2000;231(5):743–51.
Scheele J, et al. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 1991;110(1):13–29.
Martin R, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg. 2003;197(2):233–41; discussion 241–2.
Yan TD, et al. Synchronous resection of colorectal primary cancer and liver metastases. World J Surg. 2007;31(7):1496–501.
Bodingbauer M, et al. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg. 2007;94(9):1133–8.
Pawlik TM, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241(5):715–22; discussion 722–4.
Woodington GF, Waugh JM. Results of resection of metastatic tumors of the liver. Am J Surg. 1963;105:24–9.
Martinet O, Reis ED, Gillet M. Gene therapy and liver metastases. Schweiz Med Wochenschr. 1999;129(34):1187–95.
Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109(4):718–26.
Thelen A, et al. Liver resection for metastases from breast cancer. J Surg Oncol. 2008;97(1):25–9.
Adam R, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg. 2006;244(4):524–35.
Kubota K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26(5):1176–81.
Soyer P, et al. Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision making. Radiology. 1992;184(3):695–7.
Jenkins RL, Pinson CW, Stone MD. Experience with transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol. 1989;23(Suppl):S104–9.
Olausson M, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl. 2007;13(3):327–33.
Adam R, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240(4):644–57; discussion 657–8.
Bismuth H, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224(4):509–20; discussion 520–2.
Bismuth H, Sherlock DJ. Revolution in liver surgery. J Gastroenterol Hepatol. 1990;5 Suppl 1:95–109.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Li, K., Yang, J., Liu, C., Chen, P. (2016). Liver Resection of Secondary Liver Cancer. In: Yan, L. (eds) Operative Techniques in Liver Resection. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7411-6_17
Download citation
DOI: https://doi.org/10.1007/978-94-017-7411-6_17
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7409-3
Online ISBN: 978-94-017-7411-6
eBook Packages: MedicineMedicine (R0)